APPLICATION
NDA219474
TYPE
NDA
ORIGINAL APPROVAL
2026-02-12
LATEST ACTION
2026-02-12
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription
Products
ADQUEY · ReferencePrescription
DIFAMILAST 1% · OINTMENT · TOPICAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.